nodes	percent_of_prediction	percent_of_DWPC	metapath
Beclomethasone—CYP3A5—Gefitinib—lung cancer	0.154	0.197	CbGbCtD
Beclomethasone—CYP3A5—Teniposide—lung cancer	0.15	0.191	CbGbCtD
Beclomethasone—CYP3A5—Crizotinib—lung cancer	0.0946	0.121	CbGbCtD
Beclomethasone—CYP3A5—Erlotinib—lung cancer	0.0913	0.117	CbGbCtD
Beclomethasone—CYP3A5—Paclitaxel—lung cancer	0.0836	0.107	CbGbCtD
Beclomethasone—CYP3A5—Irinotecan—lung cancer	0.0824	0.105	CbGbCtD
Beclomethasone—CYP3A5—Etoposide—lung cancer	0.066	0.0844	CbGbCtD
Beclomethasone—CYP3A5—Docetaxel—lung cancer	0.0604	0.0772	CbGbCtD
Beclomethasone—Lacrimation increased—Pemetrexed—lung cancer	0.00436	0.0286	CcSEcCtD
Beclomethasone—Ulcer—Gefitinib—lung cancer	0.00422	0.0277	CcSEcCtD
Beclomethasone—Amcinonide—ANXA1—lung cancer	0.00346	0.407	CrCbGaD
Beclomethasone—Dysmenorrhoea—Topotecan—lung cancer	0.00265	0.0174	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—BPTF—lung cancer	0.00211	0.0374	CbGpPWpGaD
Beclomethasone—Epistaxis—Gefitinib—lung cancer	0.00211	0.0138	CcSEcCtD
Beclomethasone—Bronchospasm—Teniposide—lung cancer	0.00201	0.0132	CcSEcCtD
Beclomethasone—Pharyngitis—Pemetrexed—lung cancer	0.002	0.0131	CcSEcCtD
Beclomethasone—Rhinorrhoea—Cisplatin—lung cancer	0.00191	0.0125	CcSEcCtD
Beclomethasone—Ageusia—Cisplatin—lung cancer	0.00191	0.0125	CcSEcCtD
Beclomethasone—Lacrimation increased—Irinotecan—lung cancer	0.00185	0.0121	CcSEcCtD
Beclomethasone—Ulcer—Irinotecan—lung cancer	0.0018	0.0118	CcSEcCtD
Beclomethasone—Ulcer—Gemcitabine—lung cancer	0.00175	0.0115	CcSEcCtD
Beclomethasone—Rhinorrhoea—Paclitaxel—lung cancer	0.00171	0.0112	CcSEcCtD
Beclomethasone—Dysphonia—Paclitaxel—lung cancer	0.00169	0.0111	CcSEcCtD
Beclomethasone—CYP3A5—Xenobiotics—CYP2A7—lung cancer	0.00166	0.0294	CbGpPWpGaD
Beclomethasone—Ulcer—Cisplatin—lung cancer	0.00163	0.0107	CcSEcCtD
Beclomethasone—Angioedema—Gefitinib—lung cancer	0.00159	0.0104	CcSEcCtD
Beclomethasone—CYP3A5—Irinotecan Pathway—UGT1A1—lung cancer	0.00158	0.0279	CbGpPWpGaD
Beclomethasone—Infection—Crizotinib—lung cancer	0.00156	0.0102	CcSEcCtD
Beclomethasone—Cough—Gefitinib—lung cancer	0.00152	0.00998	CcSEcCtD
Beclomethasone—Lacrimation increased—Paclitaxel—lung cancer	0.00151	0.00987	CcSEcCtD
Beclomethasone—Wheezing—Cisplatin—lung cancer	0.0015	0.00983	CcSEcCtD
Beclomethasone—Ulcer—Etoposide—lung cancer	0.0015	0.00981	CcSEcCtD
Beclomethasone—Rhinorrhoea—Docetaxel—lung cancer	0.00145	0.00952	CcSEcCtD
Beclomethasone—Ageusia—Docetaxel—lung cancer	0.00145	0.00952	CcSEcCtD
Beclomethasone—Anaphylactic shock—Pemetrexed—lung cancer	0.00143	0.00939	CcSEcCtD
Beclomethasone—Infection—Pemetrexed—lung cancer	0.00142	0.00933	CcSEcCtD
Beclomethasone—Infection—Gefitinib—lung cancer	0.00141	0.00927	CcSEcCtD
Beclomethasone—CYP3A5—Irinotecan Pathway—ABCG2—lung cancer	0.00137	0.0242	CbGpPWpGaD
Beclomethasone—Wheezing—Paclitaxel—lung cancer	0.00135	0.00883	CcSEcCtD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.0013	0.0231	CbGpPWpGaD
Beclomethasone—Lacrimation increased—Docetaxel—lung cancer	0.00128	0.00836	CcSEcCtD
Beclomethasone—Bronchospasm—Vinorelbine—lung cancer	0.00127	0.00834	CcSEcCtD
Beclomethasone—Epistaxis—Topotecan—lung cancer	0.00127	0.00834	CcSEcCtD
Beclomethasone—Epistaxis—Erlotinib—lung cancer	0.00126	0.00825	CcSEcCtD
Beclomethasone—Lightheadedness—Paclitaxel—lung cancer	0.00124	0.00814	CcSEcCtD
Beclomethasone—Pharyngitis—Vinblastine—lung cancer	0.00124	0.00811	CcSEcCtD
Beclomethasone—Nasal congestion—Cisplatin—lung cancer	0.00123	0.00807	CcSEcCtD
Beclomethasone—Pain—Pemetrexed—lung cancer	0.00123	0.00803	CcSEcCtD
Beclomethasone—Pain—Gefitinib—lung cancer	0.00122	0.00798	CcSEcCtD
Beclomethasone—Pharyngitis—Topotecan—lung cancer	0.0012	0.00788	CcSEcCtD
Beclomethasone—Infection—Teniposide—lung cancer	0.00115	0.00756	CcSEcCtD
Beclomethasone—Urticaria—Pemetrexed—lung cancer	0.00114	0.00746	CcSEcCtD
Beclomethasone—Urticaria—Gefitinib—lung cancer	0.00113	0.00741	CcSEcCtD
Beclomethasone—Nasal congestion—Paclitaxel—lung cancer	0.00111	0.00725	CcSEcCtD
Beclomethasone—Dexamethasone—ANXA1—lung cancer	0.00109	0.128	CrCbGaD
Beclomethasone—Lightheadedness—Docetaxel—lung cancer	0.00105	0.0069	CcSEcCtD
Beclomethasone—Dizziness—Crizotinib—lung cancer	0.00104	0.0068	CcSEcCtD
Beclomethasone—Bronchospasm—Gemcitabine—lung cancer	0.00102	0.0067	CcSEcCtD
Beclomethasone—Back pain—Topotecan—lung cancer	0.00102	0.00668	CcSEcCtD
Beclomethasone—Back pain—Erlotinib—lung cancer	0.00101	0.00661	CcSEcCtD
Beclomethasone—Nasopharyngitis—Cisplatin—lung cancer	0.001	0.00657	CcSEcCtD
Beclomethasone—Rash—Crizotinib—lung cancer	0.000988	0.00648	CcSEcCtD
Beclomethasone—Dermatitis—Crizotinib—lung cancer	0.000987	0.00647	CcSEcCtD
Beclomethasone—NR3C1—Nuclear Receptors—RARB—lung cancer	0.000969	0.0172	CbGpPWpGaD
Beclomethasone—CYP3A5—Xenobiotics—CYP2A6—lung cancer	0.000966	0.0171	CbGpPWpGaD
Beclomethasone—Angioedema—Topotecan—lung cancer	0.000963	0.00631	CcSEcCtD
Beclomethasone—Dizziness—Pemetrexed—lung cancer	0.000947	0.00621	CcSEcCtD
Beclomethasone—Nausea—Crizotinib—lung cancer	0.000931	0.00611	CcSEcCtD
Beclomethasone—CYP3A5—Tamoxifen metabolism—CYP2A6—lung cancer	0.000929	0.0164	CbGpPWpGaD
Beclomethasone—Urticaria—Teniposide—lung cancer	0.000922	0.00604	CcSEcCtD
Beclomethasone—Cough—Topotecan—lung cancer	0.00092	0.00603	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00092	0.0163	CbGpPWpGaD
Beclomethasone—Cough—Erlotinib—lung cancer	0.00091	0.00597	CcSEcCtD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000907	0.0161	CbGpPWpGaD
Beclomethasone—Ageusia—Doxorubicin—lung cancer	0.000906	0.00594	CcSEcCtD
Beclomethasone—Rash—Pemetrexed—lung cancer	0.000903	0.00592	CcSEcCtD
Beclomethasone—Dermatitis—Pemetrexed—lung cancer	0.000902	0.00592	CcSEcCtD
Beclomethasone—Nasopharyngitis—Paclitaxel—lung cancer	0.0009	0.0059	CcSEcCtD
Beclomethasone—Rash—Gefitinib—lung cancer	0.000898	0.00588	CcSEcCtD
Beclomethasone—Dermatitis—Gefitinib—lung cancer	0.000897	0.00588	CcSEcCtD
Beclomethasone—Ulcer—Methotrexate—lung cancer	0.000896	0.00587	CcSEcCtD
Beclomethasone—Dysphonia—Doxorubicin—lung cancer	0.000892	0.00585	CcSEcCtD
Beclomethasone—Bronchospasm—Etoposide—lung cancer	0.000873	0.00572	CcSEcCtD
Beclomethasone—Back pain—Vinorelbine—lung cancer	0.000872	0.00572	CcSEcCtD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000865	0.0153	CbGpPWpGaD
Beclomethasone—Anaphylactic shock—Topotecan—lung cancer	0.00086	0.00564	CcSEcCtD
Beclomethasone—Infection—Topotecan—lung cancer	0.000854	0.0056	CcSEcCtD
Beclomethasone—Nausea—Pemetrexed—lung cancer	0.000851	0.00558	CcSEcCtD
Beclomethasone—Nausea—Gefitinib—lung cancer	0.000846	0.00554	CcSEcCtD
Beclomethasone—Infection—Erlotinib—lung cancer	0.000845	0.00554	CcSEcCtD
Beclomethasone—Pharyngitis—Gemcitabine—lung cancer	0.000826	0.00541	CcSEcCtD
Beclomethasone—Angioedema—Vinorelbine—lung cancer	0.000824	0.0054	CcSEcCtD
Beclomethasone—CYP3A5—Xenobiotics—CYP2E1—lung cancer	0.000821	0.0145	CbGpPWpGaD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000813	0.0144	CbGpPWpGaD
Beclomethasone—Lacrimation increased—Doxorubicin—lung cancer	0.000796	0.00522	CcSEcCtD
Beclomethasone—CYP3A5—Tamoxifen metabolism—CYP2E1—lung cancer	0.00079	0.014	CbGpPWpGaD
Beclomethasone—Cough—Vinorelbine—lung cancer	0.000787	0.00516	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.000782	0.0138	CbGpPWpGaD
Beclomethasone—Ulcer—Doxorubicin—lung cancer	0.000776	0.00509	CcSEcCtD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.000765	0.0136	CbGpPWpGaD
Beclomethasone—Nasopharyngitis—Docetaxel—lung cancer	0.000763	0.005	CcSEcCtD
Beclomethasone—Pain—Vinblastine—lung cancer	0.000757	0.00496	CcSEcCtD
Beclomethasone—Anaphylactic shock—Vinorelbine—lung cancer	0.000736	0.00482	CcSEcCtD
Beclomethasone—Pain—Topotecan—lung cancer	0.000735	0.00482	CcSEcCtD
Beclomethasone—Epistaxis—Paclitaxel—lung cancer	0.000732	0.0048	CcSEcCtD
Beclomethasone—Rash—Teniposide—lung cancer	0.000732	0.0048	CcSEcCtD
Beclomethasone—Dermatitis—Teniposide—lung cancer	0.000731	0.00479	CcSEcCtD
Beclomethasone—Infection—Vinorelbine—lung cancer	0.000731	0.00479	CcSEcCtD
Beclomethasone—Sinusitis—Paclitaxel—lung cancer	0.000728	0.00477	CcSEcCtD
Beclomethasone—Pain—Erlotinib—lung cancer	0.000728	0.00477	CcSEcCtD
Beclomethasone—Headache—Teniposide—lung cancer	0.000727	0.00477	CcSEcCtD
Beclomethasone—Bronchospasm—Docetaxel—lung cancer	0.000726	0.00476	CcSEcCtD
Beclomethasone—Back pain—Irinotecan—lung cancer	0.000719	0.00472	CcSEcCtD
Beclomethasone—Back pain—Gemcitabine—lung cancer	0.000701	0.00459	CcSEcCtD
Beclomethasone—Pharyngitis—Paclitaxel—lung cancer	0.000691	0.00453	CcSEcCtD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00069	0.0122	CbGpPWpGaD
Beclomethasone—Nausea—Teniposide—lung cancer	0.000689	0.00452	CcSEcCtD
Beclomethasone—Urticaria—Topotecan—lung cancer	0.000683	0.00448	CcSEcCtD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000681	0.0121	CbGpPWpGaD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000663	0.0117	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.000658	0.0117	CbGpPWpGaD
Beclomethasone—Cough—Irinotecan—lung cancer	0.000649	0.00425	CcSEcCtD
Beclomethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.000636	0.0113	CbGpPWpGaD
Beclomethasone—Cough—Gemcitabine—lung cancer	0.000632	0.00414	CcSEcCtD
Beclomethasone—Pain—Vinorelbine—lung cancer	0.000629	0.00413	CcSEcCtD
Beclomethasone—Clobetasol propionate—CYP1A1—lung cancer	0.000624	0.0734	CrCbGaD
Beclomethasone—Epistaxis—Docetaxel—lung cancer	0.00062	0.00407	CcSEcCtD
Beclomethasone—CYP3A5—Irinotecan Pathway—APC—lung cancer	0.000615	0.0109	CbGpPWpGaD
Beclomethasone—Anaphylactic shock—Irinotecan—lung cancer	0.000607	0.00398	CcSEcCtD
Beclomethasone—Infection—Irinotecan—lung cancer	0.000603	0.00395	CcSEcCtD
Beclomethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.000598	0.0106	CbGpPWpGaD
Beclomethasone—Back pain—Etoposide—lung cancer	0.000598	0.00392	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.000593	0.0105	CbGpPWpGaD
Beclomethasone—Anaphylactic shock—Gemcitabine—lung cancer	0.000591	0.00388	CcSEcCtD
Beclomethasone—CYP3A5—Xenobiotics—CYP1A1—lung cancer	0.00059	0.0104	CbGpPWpGaD
Beclomethasone—Infection—Gemcitabine—lung cancer	0.000587	0.00385	CcSEcCtD
Beclomethasone—Back pain—Paclitaxel—lung cancer	0.000587	0.00385	CcSEcCtD
Beclomethasone—Pharyngitis—Docetaxel—lung cancer	0.000586	0.00384	CcSEcCtD
Beclomethasone—Dizziness—Vinblastine—lung cancer	0.000585	0.00384	CcSEcCtD
Beclomethasone—Prednisolone—CYP2A6—lung cancer	0.000585	0.0688	CrCbGaD
Beclomethasone—Urticaria—Vinorelbine—lung cancer	0.000584	0.00383	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.000579	0.0103	CbGpPWpGaD
Beclomethasone—Dizziness—Topotecan—lung cancer	0.000569	0.00373	CcSEcCtD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.000568	0.0101	CbGpPWpGaD
Beclomethasone—CYP3A5—Tamoxifen metabolism—CYP1A1—lung cancer	0.000567	0.01	CbGpPWpGaD
Beclomethasone—Dizziness—Erlotinib—lung cancer	0.000563	0.00369	CcSEcCtD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00056	0.00991	CbGpPWpGaD
Beclomethasone—Headache—Vinblastine—lung cancer	0.000555	0.00364	CcSEcCtD
Beclomethasone—Angioedema—Paclitaxel—lung cancer	0.000554	0.00363	CcSEcCtD
Beclomethasone—Anaphylactic shock—Cisplatin—lung cancer	0.000551	0.00361	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.000548	0.00971	CbGpPWpGaD
Beclomethasone—Infection—Cisplatin—lung cancer	0.000547	0.00359	CcSEcCtD
Beclomethasone—Rash—Topotecan—lung cancer	0.000542	0.00356	CcSEcCtD
Beclomethasone—Dermatitis—Topotecan—lung cancer	0.000542	0.00355	CcSEcCtD
Beclomethasone—Cough—Etoposide—lung cancer	0.00054	0.00354	CcSEcCtD
Beclomethasone—Headache—Topotecan—lung cancer	0.000539	0.00353	CcSEcCtD
Beclomethasone—Rash—Erlotinib—lung cancer	0.000537	0.00352	CcSEcCtD
Beclomethasone—Dermatitis—Erlotinib—lung cancer	0.000536	0.00351	CcSEcCtD
Beclomethasone—Headache—Erlotinib—lung cancer	0.000533	0.0035	CcSEcCtD
Beclomethasone—Cough—Paclitaxel—lung cancer	0.000529	0.00347	CcSEcCtD
Beclomethasone—Nausea—Vinblastine—lung cancer	0.000526	0.00345	CcSEcCtD
Beclomethasone—Pain—Irinotecan—lung cancer	0.000519	0.0034	CcSEcCtD
Beclomethasone—Nausea—Topotecan—lung cancer	0.000511	0.00335	CcSEcCtD
Beclomethasone—Pain—Gemcitabine—lung cancer	0.000505	0.00331	CcSEcCtD
Beclomethasone—Nausea—Erlotinib—lung cancer	0.000505	0.00331	CcSEcCtD
Beclomethasone—Anaphylactic shock—Etoposide—lung cancer	0.000505	0.00331	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.000504	0.00892	CbGpPWpGaD
Beclomethasone—Infection—Etoposide—lung cancer	0.000501	0.00329	CcSEcCtD
Beclomethasone—Back pain—Docetaxel—lung cancer	0.000497	0.00326	CcSEcCtD
Beclomethasone—Anaphylactic shock—Paclitaxel—lung cancer	0.000495	0.00324	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.000494	0.00875	CbGpPWpGaD
Beclomethasone—Infection—Paclitaxel—lung cancer	0.000492	0.00322	CcSEcCtD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.000488	0.00864	CbGpPWpGaD
Beclomethasone—Dizziness—Vinorelbine—lung cancer	0.000487	0.00319	CcSEcCtD
Beclomethasone—Nasopharyngitis—Doxorubicin—lung cancer	0.000476	0.00312	CcSEcCtD
Beclomethasone—Pain—Cisplatin—lung cancer	0.000471	0.00309	CcSEcCtD
Beclomethasone—Rash—Vinorelbine—lung cancer	0.000464	0.00304	CcSEcCtD
Beclomethasone—Dermatitis—Vinorelbine—lung cancer	0.000463	0.00304	CcSEcCtD
Beclomethasone—Headache—Vinorelbine—lung cancer	0.000461	0.00302	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.000455	0.00805	CbGpPWpGaD
Beclomethasone—NR3C1—Endoderm Differentiation—APP—lung cancer	0.000449	0.00795	CbGpPWpGaD
Beclomethasone—Cough—Docetaxel—lung cancer	0.000448	0.00294	CcSEcCtD
Beclomethasone—Epistaxis—Methotrexate—lung cancer	0.000447	0.00293	CcSEcCtD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.00044	0.00779	CbGpPWpGaD
Beclomethasone—Nausea—Vinorelbine—lung cancer	0.000437	0.00287	CcSEcCtD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.000433	0.00767	CbGpPWpGaD
Beclomethasone—Pain—Etoposide—lung cancer	0.000432	0.00283	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.000424	0.00752	CbGpPWpGaD
Beclomethasone—Pain—Paclitaxel—lung cancer	0.000423	0.00277	CcSEcCtD
Beclomethasone—Pharyngitis—Methotrexate—lung cancer	0.000422	0.00277	CcSEcCtD
Beclomethasone—Anaphylactic shock—Docetaxel—lung cancer	0.000419	0.00275	CcSEcCtD
Beclomethasone—Infection—Docetaxel—lung cancer	0.000417	0.00273	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.000416	0.00736	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—AVP—lung cancer	0.000414	0.00733	CbGpPWpGaD
Beclomethasone—Dizziness—Irinotecan—lung cancer	0.000401	0.00263	CcSEcCtD
Beclomethasone—Urticaria—Etoposide—lung cancer	0.000401	0.00263	CcSEcCtD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000401	0.0071	CbGpPWpGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000396	0.00701	CbGpPWpGaD
Beclomethasone—Urticaria—Paclitaxel—lung cancer	0.000393	0.00258	CcSEcCtD
Beclomethasone—Fluticasone furoate—ABCB1—lung cancer	0.000388	0.0456	CrCbGaD
Beclomethasone—Epistaxis—Doxorubicin—lung cancer	0.000387	0.00254	CcSEcCtD
Beclomethasone—Sinusitis—Doxorubicin—lung cancer	0.000385	0.00252	CcSEcCtD
Beclomethasone—Rash—Irinotecan—lung cancer	0.000383	0.00251	CcSEcCtD
Beclomethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.000383	0.00677	CbGpPWpGaD
Beclomethasone—Dermatitis—Irinotecan—lung cancer	0.000382	0.00251	CcSEcCtD
Beclomethasone—Headache—Irinotecan—lung cancer	0.00038	0.00249	CcSEcCtD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.000378	0.0067	CbGpPWpGaD
Beclomethasone—Rash—Gemcitabine—lung cancer	0.000373	0.00244	CcSEcCtD
Beclomethasone—Dermatitis—Gemcitabine—lung cancer	0.000372	0.00244	CcSEcCtD
Beclomethasone—Headache—Gemcitabine—lung cancer	0.00037	0.00243	CcSEcCtD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.000368	0.00651	CbGpPWpGaD
Beclomethasone—Pharyngitis—Doxorubicin—lung cancer	0.000366	0.0024	CcSEcCtD
Beclomethasone—NR3C1—Adipogenesis—AHR—lung cancer	0.000362	0.00641	CbGpPWpGaD
Beclomethasone—Nausea—Irinotecan—lung cancer	0.00036	0.00236	CcSEcCtD
Beclomethasone—Pain—Docetaxel—lung cancer	0.000359	0.00235	CcSEcCtD
Beclomethasone—Back pain—Methotrexate—lung cancer	0.000358	0.00235	CcSEcCtD
Beclomethasone—Nausea—Gemcitabine—lung cancer	0.000351	0.0023	CcSEcCtD
Beclomethasone—Rash—Cisplatin—lung cancer	0.000347	0.00228	CcSEcCtD
Beclomethasone—Dermatitis—Cisplatin—lung cancer	0.000347	0.00228	CcSEcCtD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000341	0.00604	CbGpPWpGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000336	0.00596	CbGpPWpGaD
Beclomethasone—Dizziness—Etoposide—lung cancer	0.000334	0.00219	CcSEcCtD
Beclomethasone—Dexamethasone—CYP2A6—lung cancer	0.000333	0.0392	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTM2—lung cancer	0.000329	0.00582	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CNDP2—lung cancer	0.000329	0.00582	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000328	0.00581	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—HIF1A—lung cancer	0.000328	0.00581	CbGpPWpGaD
Beclomethasone—Dizziness—Paclitaxel—lung cancer	0.000327	0.00215	CcSEcCtD
Beclomethasone—Nausea—Cisplatin—lung cancer	0.000327	0.00215	CcSEcCtD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000325	0.00576	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTM2—lung cancer	0.000324	0.00574	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.000324	0.00574	CbGpPWpGaD
Beclomethasone—Cough—Methotrexate—lung cancer	0.000323	0.00212	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.000321	0.00568	CbGpPWpGaD
Beclomethasone—Rash—Etoposide—lung cancer	0.000318	0.00209	CcSEcCtD
Beclomethasone—Dermatitis—Etoposide—lung cancer	0.000318	0.00208	CcSEcCtD
Beclomethasone—Headache—Etoposide—lung cancer	0.000316	0.00207	CcSEcCtD
Beclomethasone—Rash—Paclitaxel—lung cancer	0.000312	0.00205	CcSEcCtD
Beclomethasone—Dermatitis—Paclitaxel—lung cancer	0.000312	0.00204	CcSEcCtD
Beclomethasone—Back pain—Doxorubicin—lung cancer	0.00031	0.00203	CcSEcCtD
Beclomethasone—Headache—Paclitaxel—lung cancer	0.00031	0.00203	CcSEcCtD
Beclomethasone—Triamcinolone—PTGS2—lung cancer	0.000306	0.036	CrCbGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000305	0.0054	CbGpPWpGaD
Beclomethasone—Anaphylactic shock—Methotrexate—lung cancer	0.000302	0.00198	CcSEcCtD
Beclomethasone—Infection—Methotrexate—lung cancer	0.0003	0.00197	CcSEcCtD
Beclomethasone—NR3C1—Adipogenesis—LMNA—lung cancer	0.0003	0.00531	CbGpPWpGaD
Beclomethasone—Nausea—Etoposide—lung cancer	0.0003	0.00197	CcSEcCtD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.0003	0.00531	CbGpPWpGaD
Beclomethasone—Dexamethasone—ABCG2—lung cancer	0.000298	0.0351	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP2A7—lung cancer	0.000297	0.00526	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000295	0.00523	CbGpPWpGaD
Beclomethasone—Nausea—Paclitaxel—lung cancer	0.000294	0.00193	CcSEcCtD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP2A7—lung cancer	0.000293	0.00519	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.000285	0.00506	CbGpPWpGaD
Beclomethasone—Cough—Doxorubicin—lung cancer	0.00028	0.00184	CcSEcCtD
Beclomethasone—Dizziness—Docetaxel—lung cancer	0.000277	0.00182	CcSEcCtD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000276	0.00489	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000276	0.00489	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000273	0.00483	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.00027	0.00479	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000268	0.00474	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTA3—lung cancer	0.000265	0.00469	CbGpPWpGaD
Beclomethasone—Rash—Docetaxel—lung cancer	0.000264	0.00173	CcSEcCtD
Beclomethasone—Dermatitis—Docetaxel—lung cancer	0.000264	0.00173	CcSEcCtD
Beclomethasone—Headache—Docetaxel—lung cancer	0.000263	0.00172	CcSEcCtD
Beclomethasone—Anaphylactic shock—Doxorubicin—lung cancer	0.000262	0.00172	CcSEcCtD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTA3—lung cancer	0.000261	0.00463	CbGpPWpGaD
Beclomethasone—Infection—Doxorubicin—lung cancer	0.00026	0.00171	CcSEcCtD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000259	0.00459	CbGpPWpGaD
Beclomethasone—Pain—Methotrexate—lung cancer	0.000259	0.0017	CcSEcCtD
Beclomethasone—Betamethasone—PTGS2—lung cancer	0.000251	0.0295	CrCbGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000251	0.00444	CbGpPWpGaD
Beclomethasone—Nausea—Docetaxel—lung cancer	0.000249	0.00163	CcSEcCtD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000249	0.00441	CbGpPWpGaD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000245	0.00434	CbGpPWpGaD
Beclomethasone—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000244	0.00432	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTA4—lung cancer	0.000242	0.00429	CbGpPWpGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000242	0.00428	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.00024	0.00426	CbGpPWpGaD
Beclomethasone—Urticaria—Methotrexate—lung cancer	0.00024	0.00157	CcSEcCtD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTA4—lung cancer	0.000239	0.00423	CbGpPWpGaD
Beclomethasone—Dexamethasone—CYP2E1—lung cancer	0.000237	0.0278	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTA2—lung cancer	0.000236	0.00418	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000234	0.00415	CbGpPWpGaD
Beclomethasone—Dexamethasone—CYP1A1—lung cancer	0.000234	0.0275	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTA1—lung cancer	0.000228	0.00404	CbGpPWpGaD
Beclomethasone—Pain—Doxorubicin—lung cancer	0.000224	0.00147	CcSEcCtD
Beclomethasone—Prednisolone—ABCB1—lung cancer	0.000218	0.0256	CrCbGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—AKR1C1—lung cancer	0.000215	0.00381	CbGpPWpGaD
Beclomethasone—Betamethasone—ABCB1—lung cancer	0.000213	0.0251	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—UGT1A1—lung cancer	0.000212	0.00375	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—UGT1A1—lung cancer	0.000209	0.0037	CbGpPWpGaD
Beclomethasone—Urticaria—Doxorubicin—lung cancer	0.000208	0.00136	CcSEcCtD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000204	0.00361	CbGpPWpGaD
Beclomethasone—Dizziness—Methotrexate—lung cancer	0.0002	0.00131	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.0002	0.00354	CbGpPWpGaD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000199	0.00352	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000197	0.00348	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000195	0.00345	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000193	0.00343	CbGpPWpGaD
Beclomethasone—Rash—Methotrexate—lung cancer	0.000191	0.00125	CcSEcCtD
Beclomethasone—Dermatitis—Methotrexate—lung cancer	0.00019	0.00125	CcSEcCtD
Beclomethasone—Headache—Methotrexate—lung cancer	0.000189	0.00124	CcSEcCtD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000188	0.00333	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000183	0.00324	CbGpPWpGaD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000183	0.00323	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—EP300—lung cancer	0.000182	0.00323	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—HPGDS—lung cancer	0.00018	0.00319	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.00018	0.00318	CbGpPWpGaD
Beclomethasone—Nausea—Methotrexate—lung cancer	0.00018	0.00118	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000175	0.00311	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTT1—lung cancer	0.000175	0.00309	CbGpPWpGaD
Beclomethasone—Dizziness—Doxorubicin—lung cancer	0.000173	0.00114	CcSEcCtD
Beclomethasone—CYP3A5—Biological oxidations—CYP2A6—lung cancer	0.000173	0.00306	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GCLC—lung cancer	0.000173	0.00306	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.00017	0.00301	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000169	0.00299	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000168	0.00297	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000165	0.00293	CbGpPWpGaD
Beclomethasone—Rash—Doxorubicin—lung cancer	0.000165	0.00108	CcSEcCtD
Beclomethasone—Dermatitis—Doxorubicin—lung cancer	0.000165	0.00108	CcSEcCtD
Beclomethasone—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000165	0.00292	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000165	0.00292	CbGpPWpGaD
Beclomethasone—Headache—Doxorubicin—lung cancer	0.000164	0.00108	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000163	0.00289	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000163	0.00289	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000159	0.00281	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000158	0.00279	CbGpPWpGaD
Beclomethasone—Nausea—Doxorubicin—lung cancer	0.000155	0.00102	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000155	0.00274	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.00015	0.00266	CbGpPWpGaD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000148	0.00262	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000148	0.00262	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP2E1—lung cancer	0.000147	0.0026	CbGpPWpGaD
Beclomethasone—Dexamethasone—PTGS2—lung cancer	0.000146	0.0172	CrCbGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000145	0.00257	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP2E1—lung cancer	0.000145	0.00256	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000144	0.00254	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000143	0.00252	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000142	0.00252	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000141	0.00249	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000139	0.00247	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—RB1—lung cancer	0.000134	0.00237	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000134	0.00237	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000133	0.00235	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000132	0.00234	CbGpPWpGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000132	0.00233	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000131	0.00232	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000129	0.00228	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000127	0.00225	CbGpPWpGaD
Beclomethasone—Dexamethasone—ABCB1—lung cancer	0.000124	0.0146	CrCbGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTP1—lung cancer	0.000121	0.00214	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTP1—lung cancer	0.000119	0.00211	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000119	0.0021	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000117	0.00207	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000117	0.00206	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000116	0.00206	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—KHSRP—lung cancer	0.000116	0.00206	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTM1—lung cancer	0.000111	0.00197	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTM1—lung cancer	0.00011	0.00194	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000108	0.00191	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP1A1—lung cancer	0.000105	0.00187	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP1A1—lung cancer	0.000104	0.00184	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000102	0.0018	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	9.85e-05	0.00175	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	9.76e-05	0.00173	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—CDKN1A—lung cancer	9.63e-05	0.00171	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	9.48e-05	0.00168	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—AZIN2—lung cancer	9.28e-05	0.00164	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—COL4A3BP—lung cancer	9.28e-05	0.00164	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	9.25e-05	0.00164	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	9.24e-05	0.00164	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—DICER1—lung cancer	9.18e-05	0.00163	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	8.84e-05	0.00157	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	8.68e-05	0.00154	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—STAT3—lung cancer	8.6e-05	0.00152	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	8.59e-05	0.00152	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	8.09e-05	0.00143	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	8.01e-05	0.00142	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—SKI—lung cancer	7.93e-05	0.0014	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	7.92e-05	0.0014	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ATP5H—lung cancer	7.89e-05	0.0014	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—POMC—lung cancer	7.86e-05	0.00139	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	7.5e-05	0.00133	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PLBD1—lung cancer	7.03e-05	0.00125	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—HSD17B10—lung cancer	6.43e-05	0.00114	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—RARB—lung cancer	6.36e-05	0.00113	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—NPPA—lung cancer	6.2e-05	0.0011	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—IL6—lung cancer	6e-05	0.00106	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CKB—lung cancer	5.98e-05	0.00106	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CNDP2—lung cancer	5.62e-05	0.000996	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTM2—lung cancer	5.62e-05	0.000996	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—MTMR3—lung cancer	5.47e-05	0.000968	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—HSPB1—lung cancer	5.33e-05	0.000945	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PGAM1—lung cancer	5.33e-05	0.000944	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	5.19e-05	0.000919	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP2A7—lung cancer	5.08e-05	0.0009	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—SDC4—lung cancer	4.97e-05	0.000881	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	4.91e-05	0.00087	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—NOTCH3—lung cancer	4.7e-05	0.000833	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—RRM1—lung cancer	4.53e-05	0.000802	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTA3—lung cancer	4.53e-05	0.000802	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—JUNB—lung cancer	4.45e-05	0.000788	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—B4GALT5—lung cancer	4.26e-05	0.000754	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTA4—lung cancer	4.14e-05	0.000734	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTA2—lung cancer	4.04e-05	0.000715	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTA1—lung cancer	3.9e-05	0.00069	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCC3—lung cancer	3.85e-05	0.000682	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—AKR1C1—lung cancer	3.73e-05	0.000661	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—UGT1A1—lung cancer	3.62e-05	0.000642	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GNG11—lung cancer	3.49e-05	0.000619	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALDOA—lung cancer	3.33e-05	0.000589	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ERCC2—lung cancer	3.23e-05	0.000572	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NCOA3—lung cancer	3.23e-05	0.000572	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCG2—lung cancer	3.14e-05	0.000556	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ADCY1—lung cancer	3.14e-05	0.000556	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—HPGDS—lung cancer	3.08e-05	0.000545	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ENO2—lung cancer	3.08e-05	0.000545	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PPP2R1B—lung cancer	3.06e-05	0.000542	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTT1—lung cancer	2.99e-05	0.000529	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GCLC—lung cancer	2.95e-05	0.000523	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP2A6—lung cancer	2.95e-05	0.000523	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	2.92e-05	0.000517	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ENO1—lung cancer	2.8e-05	0.000496	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP2E1—lung cancer	2.51e-05	0.000445	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NQO1—lung cancer	2.48e-05	0.00044	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—CREBBP—lung cancer	2.37e-05	0.000419	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—STK11—lung cancer	2.24e-05	0.000396	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTP1—lung cancer	2.07e-05	0.000367	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CAT—lung cancer	2.01e-05	0.000357	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCB1—lung cancer	1.96e-05	0.000347	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—TYMS—lung cancer	1.92e-05	0.000341	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTM1—lung cancer	1.9e-05	0.000337	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP1A1—lung cancer	1.8e-05	0.000319	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ERCC2—lung cancer	1.79e-05	0.000317	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOA1—lung cancer	1.55e-05	0.000274	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—MAPK3—lung cancer	1.44e-05	0.000256	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PIK3CG—lung cancer	1.41e-05	0.00025	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—MYC—lung cancer	1.4e-05	0.000249	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—POMC—lung cancer	1.34e-05	0.000238	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CREBBP—lung cancer	1.31e-05	0.000232	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PIK3CD—lung cancer	1.24e-05	0.00022	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALB—lung cancer	1.23e-05	0.000217	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PIK3CB—lung cancer	1.08e-05	0.000192	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PTGS2—lung cancer	1.07e-05	0.00019	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—AKT1—lung cancer	9.74e-06	0.000172	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PTEN—lung cancer	9.35e-06	0.000166	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—EP300—lung cancer	8.92e-06	0.000158	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PIK3CA—lung cancer	6.6e-06	0.000117	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—AKT1—lung cancer	5.39e-06	9.55e-05	CbGpPWpGaD
